Dr Ute Berger, President, Development & Commercialisation Solutions outlines how ICON is transforming clinical trials in a rapidly shifting landscape in the Executive Interview in Drug Development & Delivery.

Copyright © Drug Development & Delivery.

 

Related information

Webpage

Transforming Trials

Whitepaper

Practical considerations in transitioning to hybrid or decentralised clinical trials

Webpage

Decentralised clinical trials